Insider Trading Alert - Liquidity Service And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 13, 2013, 141 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $99.99 to $478,779,119.37.

Highlighted Stocks Traded by Insiders:

Liquidity Service (LQDT) - FREE Research Report

Angrick William P III who is Chairman of the Board and CEO at Liquidity Service sold 150,000 shares at $36.95 on Sept. 13, 2013. Following this transaction, the Chairman of the Board and CEO owned 3.7 million shares meaning that the stake was reduced by 3.94% with the 150,000 share transaction.

The shares most recently traded at $36.48, down $0.47, or 1.29% since the insider transaction. Historical insider transactions for Liquidity Service go as follows:

  • 12-Week # shares sold: 1,146
  • 24-Week # shares sold: 1,146

The average volume for Liquidity Service has been 414,100 shares per day over the past 30 days. Liquidity Service has a market cap of $1.1 billion and is part of the services sector and retail industry. Shares are down 11.43% year to date as of the close of trading on Friday.

Liquidity Services, Inc. operates various online auction marketplaces for surplus, salvage, and scrap assets in the United States. The company has a P/E ratio of 32.6. Currently there are 9 analysts that rate Liquidity Service a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on LQDT - FREE

TheStreet Quant Ratings rates Liquidity Service as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Liquidity Service Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Heartland Payment Systems (HPY) - FREE Research Report

Carr Robert O who is Chairman of the Board and CEO at Heartland Payment Systems sold 17,000 shares at $37.87 on Sept. 13, 2013. Following this transaction, the Chairman of the Board and CEO owned 277,108 shares meaning that the stake was reduced by 5.78% with the 17,000 share transaction.

The shares most recently traded at $38.01, up $0.14, or 0.37% since the insider transaction. Historical insider transactions for Heartland Payment Systems go as follows:

  • 4-Week # shares sold: 22,498
  • 12-Week # shares sold: 27,129
  • 24-Week # shares sold: 35,638

The average volume for Heartland Payment Systems has been 362,100 shares per day over the past 30 days. Heartland Payment Systems has a market cap of $1.4 billion and is part of the services sector and diversified services industry. Shares are up 26.07% year to date as of the close of trading on Friday.

Jan 2013 bought Ovation Payroll Inc. provides payroll solutions for businesses in the United States. It offers outsourced payroll solutions, including an e-payroll portal. The stock currently has a dividend yield of 0.75%. The company has a P/E ratio of 21.0. Currently there are 8 analysts that rate Heartland Payment Systems a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HPY - FREE

TheStreet Quant Ratings rates Heartland Payment Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Heartland Payment Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Cornerstone OnDemand (CSOD) - FREE Research Report

Seymour Steven D who is EVP of Strategic Accounts at Cornerstone OnDemand sold 20,000 shares at $54.25 on Sept. 13, 2013. Following this transaction, the EVP of Strategic Accounts owned 747,876 shares meaning that the stake was reduced by 2.6% with the 20,000 share transaction.

The shares most recently traded at $53.93, down $0.32, or 0.59% since the insider transaction. Historical insider transactions for Cornerstone OnDemand go as follows:

  • 4-Week # shares sold: 149,688
  • 12-Week # shares sold: 200,888
  • 24-Week # shares sold: 437,738

The average volume for Cornerstone OnDemand has been 422,600 shares per day over the past 30 days. Cornerstone OnDemand has a market cap of $2.8 billion and is part of the technology sector and computer software & services industry. Shares are up 84.9% year to date as of the close of trading on Friday.

Known for learning management products, also offer cloud recruiting solutions. Currently there are 5 analysts that rate Cornerstone OnDemand a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSOD - FREE

TheStreet Quant Ratings rates Cornerstone OnDemand as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and generally high debt management risk. Get the full Cornerstone OnDemand Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Halliburton Company (HAL) - FREE Research Report

Angelle Evelyn M who is Senior VP -Chief Acct. Officer at Halliburton Company sold 1,673 shares at $49.59 on Sept. 13, 2013. Following this transaction, the Senior VP -Chief Acct. Officer owned 41,273 shares meaning that the stake was reduced by 3.9% with the 1,673 share transaction.

The shares most recently traded at $49.92, up $0.33, or 0.66% since the insider transaction. Historical insider transactions for Halliburton Company go as follows:

  • 4-Week # shares sold: 71,549
  • 12-Week # shares sold: 125,571
  • 24-Week # shares sold: 182,000

The average volume for Halliburton Company has been 9.9 million shares per day over the past 30 days. Halliburton Company has a market cap of $44.9 billion and is part of the basic materials sector and energy industry. Shares are up 43.24% year to date as of the close of trading on Friday.

Halliburton Company provides a range of services and products for the exploration, development, and production of oil and natural gas. The company operates in two segments, Completion and Production, and Drilling and Evaluation. The stock currently has a dividend yield of 1.02%. The company has a P/E ratio of 25.0. Currently there are 18 analysts that rate Halliburton Company a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAL - FREE

TheStreet Quant Ratings rates Halliburton Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Halliburton Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Jazz Pharmaceuticals (JAZZ) - FREE Research Report

Falberg Kathryn E who is EVP and CFO at Jazz Pharmaceuticals sold 3,000 shares at $87.52 on Sept. 13, 2013. Following this transaction, the EVP and CFO owned 137,372 shares meaning that the stake was reduced by 2.14% with the 3,000 share transaction.

The shares most recently traded at $89.91, up $2.39, or 2.66% since the insider transaction. Historical insider transactions for Jazz Pharmaceuticals go as follows:

  • 4-Week # shares sold: 8,000
  • 12-Week # shares sold: 34,208
  • 24-Week # shares sold: 50,208

The average volume for Jazz Pharmaceuticals has been 791,300 shares per day over the past 30 days. Jazz Pharmaceuticals has a market cap of $5.1 billion and is part of the health care sector and drugs industry. Shares are up 64% year to date as of the close of trading on Friday.

Jazz Pharmaceuticals Public Limited Company, a specialty biopharmaceutical company, engages in the identification, development, and commercialization of pharmaceutical products for various medical needs in the United States, Europe, and other countries. The company has a P/E ratio of 18.6. Currently there are 12 analysts that rate Jazz Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JAZZ - FREE

TheStreet Quant Ratings rates Jazz Pharmaceuticals as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Jazz Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Dow Plunges on Trade War Worries but Walmart and Verizon Finish Positively

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

Tuesday Turnaround in Politics: Is a Trade War on the Horizon?

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff